Voloridge Investment Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $339,978 - $429,779	-8,432 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $153,487 - $188,879	3,679 Added 77.4%	8,432 $393,000
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $519,871 - $720,125	-14,043 Reduced 74.71%	4,753 $202,000
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $320,538 - $407,863	-7,413 Reduced 28.28%	18,796 $902,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $158,170 - $276,442	-4,602 Reduced 14.94%	26,209 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $1.67 Million - $1.98 Million	30,811 New	30,811 $1.85 Million

3.82M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $15.2M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.